<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01084694</url>
  </required_header>
  <id_info>
    <org_study_id>NSH 888</org_study_id>
    <nct_id>NCT01084694</nct_id>
  </id_info>
  <brief_title>Caregiver Burden and Distress in Hematopoeitic Stem Cell Transplant</brief_title>
  <official_title>The Impact of Hematopoeitic Stem Cell Transplantation on Primary Caregiver Level of Burden and Distress</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northside Hospital, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northside Hospital, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the impact that serving as a caregiver for a patient
      undergoing hematopoietic stem cell transplant has on the caregiver. This will include looking
      at the caregiver's level of burden, depression, anxiety, somatic symptoms, fatigue and
      overall distress. It will also look at whether caregiver burden leads to an increase in
      hospitalization and overall outcome.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 19, 2010</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Actual">September 29, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Level of distress &amp; Feelings of Burden</measure>
    <time_frame>pre-transplant to 1 year post-transplant</time_frame>
    <description>Primary objective is to investigate the level of distress and feelings of burden in caregivers of hematopoietic stem cell transplant patients.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Impact of patient distress, fatigue &amp; pain on the level of caregiver distress &amp; burden</measure>
    <time_frame>pre-transplant to one year post-transplant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact of caregiver distress and burden on overall patient survival and length of patient hospitalization</measure>
    <time_frame>Pre-transplant to 1 year post-transplant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Common characteristics of caregivers</measure>
    <time_frame>pre-transplant to one year post-transplant</time_frame>
    <description>To identify common characteristics of caregivers who report significantly more feelings of burden or distress</description>
  </secondary_outcome>
  <enrollment type="Actual">100</enrollment>
  <condition>Depression</condition>
  <condition>Anxiety</condition>
  <condition>Fatigue</condition>
  <condition>Distress</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will be an autologous patient and their caregiver and an allogeneic
        patient and their caregiver
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patient:

          -  Any patient undergoing autologous or allogeneic HSCT at The Blood and Marrow
             Transplant Program at Northside Hospital

          -  Patients must have a single primary caregiver

          -  Patients must be willing to comply with all assessments as outlined in the protocol

          -  Patients must be willing to sign informed consent

        Caregiver:

          -  Must be the primary caregiver for an autologous or allogenic HSCT patient at the Blood
             and Marrow Transplant Program at Northside Hospital

          -  Caregiver must be willing to comply will all assessments as outlined in the protocol

          -  Caregiver must be willing to sign consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dawn Speckhart, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northside Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Northside Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 9, 2010</study_first_submitted>
  <study_first_submitted_qc>March 9, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 10, 2010</study_first_posted>
  <last_update_submitted>March 27, 2018</last_update_submitted>
  <last_update_submitted_qc>March 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HSCT</keyword>
  <keyword>Caregiver</keyword>
  <keyword>Caregiver Burden</keyword>
  <keyword>Allogeneic Transplant</keyword>
  <keyword>Autologous Transplant</keyword>
  <keyword>Hematopoietic Stem Cell Transplantation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatigue</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>March 30, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

